Perceptive Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,075,000
Closed -$6.98M 117
2023
Q4
$6.98M Hold
1,075,000
0.16% 69
2023
Q3
$5.41M Buy
+1,075,000
New +$5.41M 0.18% 68
2023
Q2
Sell
-1,350,000
Closed -$16M 101
2023
Q1
$16M Buy
+1,350,000
New +$16M 0.47% 50